Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.
Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check5 days agoChange DetectedNo additions or deletions were detected; the Study Details page content, including status, locations, and eligibility criteria, remains unchanged.SummaryDifference0.1%
- Check12 days agoChange DetectedLast update date refreshed and minor wording edits were made; core study details (eligibility, intervention, outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNo significant changes detected.SummaryDifference0.2%
- Check33 days agoChange DetectedNo changes detected.SummaryDifference0.2%
- Check41 days agoChange DetectedAdded new content on bone osteosarcoma and updated to v3.2.0; removed kidney Wilms tumor and v3.1.0.SummaryDifference4%
- Check48 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.3%
Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.